
Global In Vitro ADME Testing Services Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global In Vitro ADME Testing Services market size will reach US$ million by 2031.
Testing services for ADME outside the human body
Early stages of drug discovery research, including the identification of relevant biological targets and viable lead compounds with therapeutic potential, play a crucial role in the overall success of drug candidates in preclinical and clinical studies. In particular, ADME studies are considered essential for determining the safety and efficacy of drug candidates. Currently, many contract research organizations (CROs) claim to have the necessary capabilities to provide in vitro ADME services.
LPI (LP Information)' newest research report, the “In Vitro ADME Testing Services Industry Forecast” looks at past sales and reviews total world In Vitro ADME Testing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro ADME Testing Services sales for 2025 through 2031. With In Vitro ADME Testing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro ADME Testing Services industry.
This Insight Report provides a comprehensive analysis of the global In Vitro ADME Testing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro ADME Testing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro ADME Testing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro ADME Testing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro ADME Testing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro ADME Testing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biologics
Small Molecules
Segmentation by Application:
Lood to Plasma Ratio
Caco-2 Permeability
Cytochrome (CYP) Enzyme Induction / Inhibition
Metabolic Stability
Plasma Protein Binding
Reaction Phenotyping
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Albany Molecular Research (AMRI)
Charles River Laboratories
Pharmaceutical Product Development (PPD)
RTI International
Eurofins Scientific
Evotec
Galapagos
Tecan Group
GVK Biosciences
Pharmaron
Sai Life Sciences
Shanghai Medicilon
Syngene International
WuXi AppTec
Please note: The report will take approximately 2 business days to prepare and deliver.
Testing services for ADME outside the human body
Early stages of drug discovery research, including the identification of relevant biological targets and viable lead compounds with therapeutic potential, play a crucial role in the overall success of drug candidates in preclinical and clinical studies. In particular, ADME studies are considered essential for determining the safety and efficacy of drug candidates. Currently, many contract research organizations (CROs) claim to have the necessary capabilities to provide in vitro ADME services.
LPI (LP Information)' newest research report, the “In Vitro ADME Testing Services Industry Forecast” looks at past sales and reviews total world In Vitro ADME Testing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro ADME Testing Services sales for 2025 through 2031. With In Vitro ADME Testing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro ADME Testing Services industry.
This Insight Report provides a comprehensive analysis of the global In Vitro ADME Testing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro ADME Testing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro ADME Testing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro ADME Testing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro ADME Testing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro ADME Testing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biologics
Small Molecules
Segmentation by Application:
Lood to Plasma Ratio
Caco-2 Permeability
Cytochrome (CYP) Enzyme Induction / Inhibition
Metabolic Stability
Plasma Protein Binding
Reaction Phenotyping
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Albany Molecular Research (AMRI)
Charles River Laboratories
Pharmaceutical Product Development (PPD)
RTI International
Eurofins Scientific
Evotec
Galapagos
Tecan Group
GVK Biosciences
Pharmaron
Sai Life Sciences
Shanghai Medicilon
Syngene International
WuXi AppTec
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
117 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 In Vitro ADME Testing Services Market Size by Player
- 4 In Vitro ADME Testing Services by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global In Vitro ADME Testing Services Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.